Dopamine agonists and pathologic behaviors.

Parkinson's Disease
Brendan J KelleyPeter Chiu

Abstract

The dopamine agonists ropinirole and pramipexole exhibit highly specific affinity for the cerebral dopamine D3 receptor. Use of these medications in Parkinson's disease has been complicated by the emergence of pathologic behavioral patterns such as hypersexuality, pathologic gambling, excessive hobbying, and other circumscribed obsessive-compulsive disorders of impulse control in people having no history of such disorders. These behavioral changes typically remit following discontinuation of the medication, further demonstrating a causal relationship. Expression of the D3 receptor is particularly rich within the limbic system, where it plays an important role in modulating the physiologic and emotional experience of novelty, reward, and risk assessment. Converging neuroanatomical, physiological, and behavioral science data suggest the high D3 affinity of these medications as the basis for these behavioral changes. These observations suggest the D3 receptor as a therapeutic target for obsessive-compulsive disorder and substance abuse, and improved understanding of D3 receptor function may aid drug design of future atypical antipsychotics.

References

Nov 23, 1974·British Medical Journal·D B CalneA Petrie
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·D AcciliS Fuchs
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·R BordetJ C Schwartz
Jul 21, 1998·International Journal of Andrology·I N BatovaS D Kyurkchiev
Jan 14, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E V Gurevich, J N Joyce
Nov 4, 2000·Medical Decision Making : an International Journal of the Society for Medical Decision Making·A M Bayoumi, D A Redelmeier
May 13, 2003·Nature Medicine·Erwan BézardPierre Sokoloff
Jan 12, 2005·Nature Neuroscience·Jan ReuterChristian Büchel
Apr 29, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Tatiana WitjasJean Philippe Azulay
May 12, 2005·Parkinsonism & Related Disorders·C GuigoniErwan Bezard
Jul 13, 2005·Archives of Neurology·M Leann DoddJ Eric Ahlskog
Jan 4, 2006·Archives of Pediatrics & Adolescent Medicine·Michael H BlochJames F Leckman
Apr 15, 2006·CNS & Neurological Disorders Drug Targets·P SokoloffC Gross
Sep 2, 2006·Neural Networks : the Official Journal of the International Neural Network Society·Michael J Frank
Sep 15, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Claire ArdouinPaul Krack
Oct 20, 2006·Parkinsonism & Related Disorders·Fabio BandiniLeonardo Cocito
Jan 11, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·H M M SmedingB Schmand
Jun 21, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·David A GallagherAnette Schrag
Oct 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Eugenia MamikonyanDaniel Weintraub
Sep 18, 2008·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·David KnobelAlexandre Berney
Nov 8, 2008·Annals of the New York Academy of Sciences·Shen-Yang LimJanis M Miyasaki
Feb 25, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T D HälbigC W Olanow
Jun 26, 2009·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Shen-Yang LimAndrew H Evans
Mar 13, 2010·Annals of Neurology·Thomas D L SteevesAntonio P Strafella
May 12, 2010·Archives of Neurology·Daniel WeintraubAnthony E Lang
May 25, 2010·The Journal of Pharmacology and Experimental Therapeutics·Cindy Achat-MendesRoger D Spealman
Jul 6, 2010·Behavioural Brain Research·Kenneth J ThielJanet L Neisewander
Aug 21, 2010·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A BharmalO Suchowersky
May 4, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Dimitrios KapogiannisEric M Wassermann
May 14, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Giuseppe d'OrsiL M Specchio
May 21, 2011·Brain : a Journal of Neurology·Valerie VoonMark Hallett

❮ Previous
Next ❯

Citations

Sep 26, 2012·Journal of Neurology·Ashok SriramMichael S Okun
May 1, 2013·Journal of Addiction Medicine·Lim Shanhui Gillian
Oct 9, 2014·Thérapie·Laura VrignaudAnnie-Pierre Jonville-Béra
May 16, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Stefanie ReyesGlenda M Halliday
Aug 26, 2014·Annals of the New York Academy of Sciences·Arturo BenitezMahnaz Asgharnejad
Feb 3, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Doris E PayerIsabelle Boileau
Mar 27, 2016·Revista española de geriatría y gerontología·Andrés Gamboa ArangoEnric Duaso Magaña
Jun 5, 2013·Archives of Sexual Behavior·Rocco Salvatore CalabròPlacido Bramanti
Aug 5, 2015·Psychiatry Research·Thomas F NewtonThomas R Kosten
Dec 17, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·S KasselH Stark
Dec 17, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Yasmin SchmidMatthias E Liechti
May 29, 2016·Progress in Neurobiology·S ButiniH Stark
Jul 6, 2016·Frontiers in Behavioral Neuroscience·Davide FerrazzoliGiuseppe Frazzitta
Mar 6, 2015·Arquivos de neuro-psiquiatria·Federico E MicheliGabriela B Raina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.